These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 12220539

  • 1. Thiazolidinediones as a novel class of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Cho H, Tai HH.
    Arch Biochem Biophys; 2002 Sep 15; 405(2):247-51. PubMed ID: 12220539
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents.
    Cho H, Tai HH.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec 15; 67(6):461-5. PubMed ID: 12468268
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors.
    Wu Y, Tai HH, Cho H.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1428-33. PubMed ID: 20122835
    [Abstract] [Full Text] [Related]

  • 4. Structure-activity relationship studies and biological characterization of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Duveau DY, Yasgar A, Wang Y, Hu X, Kouznetsova J, Brimacombe KR, Jadhav A, Simeonov A, Thomas CJ, Maloney DJ.
    Bioorg Med Chem Lett; 2014 Jan 15; 24(2):630-5. PubMed ID: 24360556
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Wound healing effects of new 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Piao YL, Seo SY, Lim SC, Cho H.
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec 15; 91(6):325-32. PubMed ID: 25458900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.
    Wu Y, Karna S, Choi CH, Tong M, Tai HH, Na DH, Jang CH, Cho H.
    J Med Chem; 2011 Jul 28; 54(14):5260-4. PubMed ID: 21650226
    [Abstract] [Full Text] [Related]

  • 10. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W, Greep RO.
    Adv Prostaglandin Thromboxane Res; 1976 Jul 28; 1():159-62. PubMed ID: 187034
    [Abstract] [Full Text] [Related]

  • 11. Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A.
    Berry CN, Hoult JR, Phillips JA, McCarthy TM, Agback H.
    J Pharm Pharmacol; 1985 Sep 28; 37(9):622-8. PubMed ID: 2867182
    [Abstract] [Full Text] [Related]

  • 12. Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.
    Cho H, Hamza A, Zhan CG, Tai HH.
    Arch Biochem Biophys; 2005 Jan 15; 433(2):447-53. PubMed ID: 15581601
    [Abstract] [Full Text] [Related]

  • 13. Effect of 15-hydroxyprostaglandin dehydrogenase inhibitor on wound healing.
    Seo SY, Han SI, Bae CS, Cho H, Lim SC.
    Prostaglandins Leukot Essent Fatty Acids; 2015 Jun 15; 97():35-41. PubMed ID: 25899574
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein.
    Liu Y, Tai HH.
    Biochem Pharmacol; 1985 Dec 15; 34(24):4275-8. PubMed ID: 4074386
    [Abstract] [Full Text] [Related]

  • 15. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.
    Zhou H, Yan F, Tai HH.
    Eur J Biochem; 2001 Jun 15; 268(12):3368-74. PubMed ID: 11422365
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair.
    Antczak MI, Zhang Y, Wang C, Doran J, Naidoo J, Voruganti S, Williams NS, Markowitz SD, Ready JM.
    J Med Chem; 2017 May 11; 60(9):3979-4001. PubMed ID: 28398755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ROS-Mediated 15-Hydroxyprostaglandin Dehydrogenase Degradation via Cysteine Oxidation Promotes NAD+-Mediated Epithelial-Mesenchymal Transition.
    Wang W, Hu Y, Wang X, Wang Q, Deng H.
    Cell Chem Biol; 2018 Mar 15; 25(3):255-261.e4. PubMed ID: 29307841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.